Twenty years ago, findings from a pivotal study dramatically changed the public’s perception — as well as that of some health care providers — surrounding menopausal HT. About 75% of HT prescriptions and medications were thrown away.”Since then, researchers have further refined knowledge on the benefits and risks of menopausal HT. “Several years later, when they released the age-stratified data, women who were younger than 60 years who took hormones for a decade had less CVD. The timing hypothesis was a key part of a position statement on menopausal HT released by the North American Menopause Society (NAMS) in 2017. “Overall, the evidence has supported the timing hypothesis.”Today, most medical societies have reached consensus regarding menopausal HT.

Source: New York Times April 08, 2022 13:20 UTC